Teligent ANDA for Betamethasone Dipropionate Approved
FDA has approved a Teligent ANDA for a generic copy of Promius Pharma’s Sernivo, indicated for treating mild-to-moderate plaque psoriasis in patients 18 years of age or older. Annual sales for betamethasone dipropionate are about $43 million, according to QuintilesIMS Health data.